These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18184936)

  • 21. Coincidence of immune thrombocytopenia, intracranial hemorrhage and graft-versus-host disease in an 11-year-old girl.
    Landgraf M; Siekmeyer M; Fischer L; Bierbach U; Siekmeyer W; Meixensberger J; Hirsch W; Kiess W
    Klin Padiatr; 2010 Nov; 222(6):378-82. PubMed ID: 20830662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. After eight-year-tolerance minimal i.v. anti-D infusions unleash hemolysis in a patient with immune thrombocytopenic purpura (ITP).
    Rewald MD; Francischetti MM
    Transfus Apher Sci; 2004 Apr; 30(2):105-10. PubMed ID: 15062747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?
    Crow AR; Lazarus AH
    Transfus Med Rev; 2008 Apr; 22(2):103-16. PubMed ID: 18353251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment of infectious mononucleosis-associated immune thrombocytopenia with WinRho anti-D immunoglobulin complicated by severe hemolysis.
    Olofinboba KA; Greenberg BR
    Am J Hematol; 2000 Oct; 65(2):178. PubMed ID: 10996841
    [No Abstract]   [Full Text] [Related]  

  • 25. Intravenous immunoglobulin and anti-RhD therapy in the management of immune thrombocytopenia.
    Cooper N
    Hematol Oncol Clin North Am; 2009 Dec; 23(6):1317-27. PubMed ID: 19932436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of adult idiopathic thrombocytopenic purpura.
    Nakhoul IN; Kozuch P; Varma M
    Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children.
    Freiberg A; Mauger D
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):23-7. PubMed ID: 9523746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating immune thrombocytopenic purpura and preventing Rh alloimmunization using intravenous rho (D) immune globulin.
    Sandler SG
    Transfus Med Rev; 2001 Jan; 15(1):67-76. PubMed ID: 11149979
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac) in chronic immune thrombocytopenic purpura.
    Aledort LM; Salama A; Kovaleva L; Robak T; Newland AC; Nugent DJ; Brenner B; Zenker O;
    Hematology; 2007 Aug; 12(4):289-95. PubMed ID: 17654054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute idiopathic thrombocytopenic purpura of childhood-diagnosis and therapy.
    Panepinto JA; Brousseau DC
    Pediatr Emerg Care; 2005 Oct; 21(10):691-5; quiz 696-8. PubMed ID: 16215478
    [No Abstract]   [Full Text] [Related]  

  • 31. Anti-D immunoglobulin in the treatment of idiopathic thrombocytopenic purpura.
    Krishnamurti L; Charan VD; Desai N; Pati H; Choudhry VP
    Indian J Pediatr; 1994; 61(2):179-82. PubMed ID: 7927616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-D exerts a very early response in childhood acute idiopathic thrombocytopenic purpura.
    Moser AM; Shalev H; Kapelushnik J
    Pediatr Hematol Oncol; 2002 Sep; 19(6):407-11. PubMed ID: 12186363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral sinus thrombosis following IV immunoglobulin therapy of immune thrombocytopenia purpura.
    Al-Riyami AZ; Lee J; Connolly M; Shereck E
    Pediatr Blood Cancer; 2011 Jul; 57(1):157-9. PubMed ID: 21445949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-D immunoglobulin therapy for pediatric ITP: before and after the FDA's black box warning.
    Thompson JC; Klima J; Despotovic JM; O'Brien SH
    Pediatr Blood Cancer; 2013 Nov; 60(11):E149-51. PubMed ID: 23813881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transfusion-related acute lung injury following intravenous anti-D administration in an adolescent.
    Berger-Achituv S; Ellis MH; Curtis BR; Wolach B
    Am J Hematol; 2008 Aug; 83(8):676-8. PubMed ID: 18383320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical experience with anti-D in the treatment of idiopathic thrombocytopenic purpura.
    Scaradavou A; Bussel JB
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):52-7. PubMed ID: 9523749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute liver failure occurring immediately following anti-D immune globulin infusion in a patient with chronic hepatitis B infection.
    Abdelmalek MF; Hellner LB; Zumberg M; Melgen VW; Lottenberg R
    Dig Dis Sci; 2007 Apr; 52(4):914-9. PubMed ID: 17347887
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura.
    Ramadan KM; El-Agnaf M
    Clin Lab Haematol; 2005 Aug; 27(4):267-9. PubMed ID: 16048495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the effects of and earliest response rate to anti-D treatment in children with chronic idiopathic thrombocytopenic purpura: a pilot study.
    Yetgin S; Aytaç S; Olcay L; Tunç B; Ozbek N; Aydinok Y
    Turk J Pediatr; 2010; 52(2):126-31. PubMed ID: 20560246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comment on Stotler BA, Schwartz J. How we use WinRho in patients with idiopathic thrombocytopenic purpura. Transfusion 2015:55:2547-50.: This article is a comment on Stotler and Schwartz [2015] DOI: 10.1111/trf.13185.
    Simon TL
    Transfusion; 2016 Apr; 56(4):999. PubMed ID: 26920084
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.